Jinwu Financial News | Cornerstone Pharmaceuticals (02616) fluctuated and declined. As of press release, it fell 25% to HK$1.11, with a turnover of HK$12.117,300.
The company announced that as of public information released on February 16, 2024, the company is no longer one of the eligible securities for the Hang Seng Composite Index, and the company will no longer be included in the Hong Kong Stock Connect as of March 4, 2024.